Literature DB >> 1950797

Immunologic interactions of T lymphocytes with vascular endothelium.

J S Pober1, R S Cotran.   

Abstract

The data presented in this review establish that cultured human endothelial cells have the capacity to present antigens to T cells and to do so in the context of costimulators that lead to effective T cell activation. These activities raise the possibility that venular ECs, at sites of delayed hypersensitivity reactions, could be the primary antigen-presenting cell to circulating memory T cells. This putative role of ECs can explain the rapid rate of initiation of memory responses because ECs are uniquely positioned to have physical access to the pool of circulating memory T cells. Studies also suggest that ECs may present alloantigens to circulating T cells in the context of transplantation, thereby initiating rejection reactions. Nevertheless, we repeat our caveat that these proposed antigen-presenting functions of ECs have not been established in vivo. Cytokine-mediated changes, particularly induction of adhesion molecules and synthesis of lymphocyte-activating cytokines, such as IL-8, provide ECs with the potential to recruit memory T cells to inflammatory sites independent of antigen specificity. Although these functions have also not been rigorously shown to occur in vivo, immunocytochemical studies of experimental and pathological tissues provide significant support for this proposal. Similar adhesive and activating functions of ECs may apply to preferential homing of pre-T cells to thymus and naive T cells to lymph node. We conclude by noting that the weight of evidence reviewed here supports the proposal that the vascular endothelium be considered an integral part of the in vivo immune system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1950797     DOI: 10.1016/s0065-2776(08)60827-5

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  31 in total

Review 1.  The role of adhesion molecules in endothelial cell accessory function.

Authors:  J R Westphal; R M de Waal
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

2.  Down regulation of endothelial adhesion molecules in node positive breast cancer: possible failure of host defence mechanism.

Authors:  Maya Madhavan; Priya Srinivas; Elizabeth Abraham; Iqbal Ahmed; N R Vijayalekshmi; Prabha Balaram
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

3.  Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.

Authors:  T Shigenaga; A M Dannenberg; D B Lowrie; W Said; M J Urist; H Abbey; B H Schofield; P Mounts; K Sugisaki
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

4.  Expression of adhesion molecules by endothelial cells of early human decidua.

Authors:  C G Tortosa; M L Vargas; M Cámara; P Alemán; M J Montes; C Ruiz; E G Olivares
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 5.  Selectins.

Authors:  M P Bevilacqua; R M Nelson
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

6.  The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells.

Authors:  D D Sedmak; S Chaiwiriyakul; D A Knight; W J Waldmann
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Elevation of serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in bronchial asthma.

Authors:  A Koizumi; S Hashimoto; T Kobayashi; K Imai; A Yachi; T Horie
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

8.  Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies.

Authors:  M A Farrell; O Droogan; D L Secor; V Poukens; B Quinn; H V Vinters
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.

Authors:  A G Murray; J S Schechner; D E Epperson; P Sultan; J M McNiff; C C Hughes; M I Lorber; P W Askenase; J S Pober
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 10.  Liver endothelial cells: participation in host response to lymphoma metastasis.

Authors:  V Umansky; M Rocha; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.